BORDEAUX, France–(BUSINESS WIRE)–HeartFocus, the revolutionary, AI-enabled heart echo software by data-driven medtech company, DESKi, is proud to announce the launch of the HeartFocus Education app in partnership with Butterfly Network, Inc., (“Butterfly”) (NYSE: BFLY) a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software. The innovative HeartFocus […]
Coronary/Structural Heart
Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients
WASHINGTON–(BUSINESS WIRE)–Edwards Lifesciences (NYSE: EW) today announced results from the EARLY TAVR Trial, the first randomized, controlled trial designed to study the best strategy for treating asymptomatic severe aortic stenosis (AS) and the benefits of early intervention with transcatheter aortic valve replacement (TAVR). The trial results demonstrated that asymptomatic severe […]
Cleerly Secures CPT Category I Code for AI-QCT Advanced Plaque Analyses
October 28, 2024 (DENVER) – Cleerly, a pioneer in advanced cardiovascular imaging, is thrilled to announce that the American Medical Association (AMA) has approved a CPT Category I code for its AI-QCT advanced plaque analyses. This significant milestone, set to take effect January 1, 2026, marks a transformative step in […]
VAHATICOR REPORTS POSITIVE RESULTS FROM ITS A-FLUX REDUCER SYSTEM™ COMPASSIONATE USE CASES
Demonstrated a Reduction of Symptoms with Short Procedural and Recovery Times Leading Coronary Physiology Experts Appointed Co-Principal Investigators for Planned U.S. Early Feasibility Study SANTA CLARA, Calif., Oct. 28, 2024 /PRNewswire/ — VahatiCor, a leader in cardiovascular…
BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure
BioCardia announced today the completion of its last protocol specified follow-up visit in CardiAMP HF multi-center trial.
Impella ECP Pivotal Study Demonstrates Safety, Efficacy for Use in High-Risk PCI
DANVERS, Mass., Oct. 28, 2024 /PRNewswire/ — Results were presented at Transcatheter Cardiovascular Therapeutics (TCT) 2024 conference from the first completed pivotal trial on patients supported with Impella ECP™, a novel transvalvular axial flow pump with compressible pump architecture….
JACC: Cardiovascular Interventions Publishes Peer-Reviewed Article on Emerging Hybrid Intracoronary Imaging Technologies
– Conavi Medical’s Novasight Hybrid™ System is the first technology to combine both IVUS and OCT to enable simultaneous and co-registered imaging of coronary arteries –
RAMPART Announces Collaboration with Armery Medical Technologies to Offer Radial Arm Board Solution
RAMPART, a Birmingham-based medical device company specializing in radiation shielding and orthopedic protection, announced a global collaboration agreement with Armery Medical Technologies to manufacture, sell and distribute the Armery Radial Arm Board solution. The Armery solution maximizes support and protection during radial procedures and furthers Rampart’s mission to provide market […]
PROVISION Study, First Ever Prospective RCT of CathWorks FFRangio Outcomes Compared to Invasive Wire-based Physiology in Japan, Meets its Primary Endpoint
PROVISION Study demonstrates significant economic and resource utilization advantages in FFRangio cohort compared to invasive wire-based FFR cohort WASHINGTON, Oct. 27, 2024 /PRNewswire/ — Today at the Cardiovascular Research Foundation’s annual Transcatheter Cardiovascular Therapeutics…
ADONA MEDICAL INITIATES FIRST-IN-HUMAN STUDY WITH ITS NOVEL INTERATRIAL SHUNT FOR PATIENTS WITH HEART FAILURE
Initial cases conducted in the Republic of Georgia with support from leading US cardiologists Adjustable interatrial shunt with integrated bi-atrial pressure monitoring aims to deliver a more personalized lifetime approach to heart failure management LOS GATOS, Calif., Oct. 27, 2024…



